Prof. Vandana B. Patravale
Professor of Pharmaceutics
Department of Pharmaceutical Sciences and Technology
Institute of Chemical Technology
Matunga, Mumbai 400019, India
E-mail: vb.patravale@ictmumbai.edu.in
Telephone: +91 22 3361 2217
Fax: +91 22 3361 1020
Brief Resume
Dr. Vandana B. Patravale is a highly accomplished Professor of Pharmaceutics at the Institute of Chemical Technology (ICT), Mumbai, India, with over 34 years of teaching and research experience. She earned her B. Pharm (1985), M. Pharm. Sci. (1987), and Ph.D. (Tech.) in Pharmaceutics (1992) from the University of Mumbai. Dr. Patravale is a distinguished fellow of leading scientific bodies, including the National Academy of Sciences, India (NASI), Indian National Science Academy (INSA), Indian National Academy of Engineering (INAE), Indian Chemical Society, and Maharashtra Academy of Sciences, among others.
Dr. Patravale has authored more than 200 peer-reviewed publications, 8 books, and 73 book chapters, accumulating over 16,000 citations, placing her in the top 2% of global pharmacy scientists based on productivity and impact. She holds 39 granted patents, with 65 patents under review, 3 trademark registries and a design patent, evidencing her prolific innovation in pharmaceutical sciences. Her research spans nanocarriers for infectious diseases, cancer, neurodegenerative disorders, tissue and cartilage regeneration, cosmeceuticals, medical devices like coronary stents and intrauterine devices, nano diagnostics, vaccine formulations, and advanced drug delivery systems.
Dr. Patravale is the President of the Controlled Release Society (Indian Chapter), Convener of the IPC 2025, APTI Women Forum, Vice President of the Pediatric Medicine Healthcare Initiative, and holds editorial roles in reputed journals including Elsevier’s Journal of Drug Delivery Science and Technology.
She leads a robust research group with numerous government and internationally funded projects, including Indo-Swiss, Indo-UK, Indo-Ireland, and Indo-Japan collaborations. By far her group has received grants for 22 government projects, 5 institute projects, and 37 industrial projects. Her notable accomplishments include the development and technology transfer of drug-eluting stents marketed in over 65 countries, making affordable cardiac care accessible globally.
An award-winning leader, she has received numerous honors such as the First Prize at IPA Academic Excellence Awards by Indian Pharmaceutical Alliance Academic Excellence at the 11th Global Pharmaceutical Quality Summit (GPQS) (2026), Exemplary Pharma professional Award at Lloyds International Conference on Embracing AI in Pharma World (2025), Women Leader in Pharma Category award by award by the pharma industry at CPHI and PMEC, Delhi (2025), Distinguished Alumnus Award from UDCT (2024), Most Iconic Healthcare Leader (Global, 2023), Abdul Kalam Technology Innovation National Fellowship (2021), and several prestigious national and international awards recognizing her excellence in pharmaceutical research, teaching, and innovation. Dr. Patravale is an influential mentor to over 2 Post Docs, 38 Ph.D. and 99 master’s students and an active consultant to pharmaceutical, cosmetic, and medical device industries, significantly contributing to academia-industry translational research and healthcare advancements in India and worldwide.
